This is a development-stage biopharmaceutical company focused on developing and commercializing products to treat diseases associated with inflammation. This stock is trading up 6.4% at $2.12 in recent trading.
Today's Range: $1.98-$2.14
52-week Range: $1.44-$8.89
Three-Month Average Volume: 604,652
From a technical perspective, ANTH is bouncing sharply here, right off its 50-day moving average of $1.95 with light volume. This move is pushing the stock within range of triggering a near-term breakout trade. That trade will hit once ANTH takes out some near-term overhead resistance at $2.22 with high volume.
Traders should now look for long-biased trades in ANTH, if it can sustain a move or close over $2.22 with volume that's near or above 604,652 shares. If we get that action soon, then ANTH could easily hit its April high of $2.75 or possibly even $3 in the near future.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts